Pharmaceuticals (prescription drugs) are the largest end‑user segment — they have the clinical data and the regulatory approvals. But nutraceuticals (supplements, vitamins) are the fastest‑growing. The oral thin film drugs market research study shows that nutraceuticals are growing at over 9% CAGR, driven by consumer demand for convenient, tasty supplements. Think: melatonin strips for sleep, vitamin B12 films for energy, and CBD strips for anxiety.

What's driving this? The rise of direct‑to‑consumer brands (Hims, Hers, Moonlily) that sell thin‑film supplements online. The oral thin film drugs market trends highlight that online pharmacies are the largest distribution channel, because that's how consumers discover these products — through Instagram ads, not doctors.

But nutraceuticals are not regulated as strictly as drugs. Quality varies. Some thin‑film supplements contain less active ingredient than claimed, or dissolve too slowly.

The bottom line: thin‑film supplements are convenient, but buy from reputable brands that third‑party test. And don't assume natural means safe — check with your doctor.